Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation. | Hered Cancer Clin Pract;20(1): 14, 2022 Apr 13. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

Secretaria de Estado da Saúde - BVS

Rede de Informação e Conhecimento

Localizar descritor de assunto Busca Avançada

Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation.

Park, Sarah Sohyun; Uzelac, Aleksandra; Kotsopoulos, Joanne.

Afiliação

Park SS; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada.
Uzelac A; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Kotsopoulos J; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

Hered Cancer Clin Pract ; 20(1): 14, 2022 Apr 13.

Article em En | MEDLINE | ID: mdl-35418083

Palavras-chave

BRCA1; Breast cancer; Osteoprotegerin; Prevention; RANK; Risk prediction

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article